ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)
$5.25 -0.02 (-0.3795%)
Analysed ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) News Sources
Wall Street Analysts Believe ABCELLERA BIOLG (ABCL) Could Rally 97.28%: Here's is How to Trade
22-05-2026
yahoo.com
Here’s Why AbCellera (ABCL) is Among the 10 Best Penny Stocks to Buy for Long Term
22-05-2026
yahoo.com
Does AbCellera (ABCL) Have a Clear Path From ABCL635 Data to a Durable Business Model?
24-05-2026
yahoo.com
After Golden Cross, AbCellera Biologics Inc. (ABCL)'s Technical Outlook is Bright
29-05-2026
yahoo.com
Has ABCELLERA BIOLG (ABCL) Outpaced Other Medical Stocks This Year?
01-06-2026
yahoo.com
AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam
04-06-2026
marketbeat.com
AbCellera Appoints Dr. Victor Sandor to its Board of Directors
05-06-2026
yahoo.com
AbCellera’s Shift To Proprietary Drugs Puts ABCL635 And Governance In Focus
07-06-2026
yahoo.com
A Look At AbCellera Biologics (ABCL) Valuation After ABCL635 Progress And Strong Q1 Results
07-06-2026
yahoo.com
Wall Street Analysts Think ABCELLERA BIOLG (ABCL) Could Surge 85.59%: Read This Before Placing a Bet
08-06-2026
yahoo.com
What is the current price of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The current price of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is $5.25.
ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) absolute price change since previous trading day?
The absolute price change of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) since the previous trading day is $-0.02.
ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) percentage price change since previous trading day?
The percentage price change of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) since the previous trading day is -0.3795%.
What is the most recent average sentiment score for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The most recent average sentiment score for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The most recent sentiment for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is .
SEC-8K** Filing Available For ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.